NCT03153735 is a NA clinical trial of CMDHA0101 in Small Penis, sponsored by CHA MEDITECH Co., Ltd..

Who is sponsoring NCT03153735?

NCT03153735 is sponsored by CHA MEDITECH Co., Ltd..

What drugs are being tested in NCT03153735?

Interventions in NCT03153735: CMDHA0101, PowerFill®.

What condition does NCT03153735 study?

NCT03153735 studies Small Penis, Penile Enhancement.

Is NCT03153735 still recruiting?

NCT03153735 is currently completed. Last updated 12 December 2017.

Last reviewed 2017-12-12 · How we verify

NCT03153735

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement

Completed NA Last updated 12 December 2017

What this trial tests

NA trial testing CMDHA0101 in Small Penis in 68 participants. Completed in 7 November 2017.

Timeline

2 December 2016

Primary endpoint
7 November 2017

7 November 2017

Quick facts

Lead sponsor	CHA MEDITECH Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	68
Start date	2 December 2016
Primary completion	7 November 2017
Estimated completion	7 November 2017
Sites	1 location across South Korea

Drugs / interventions tested

CMDHA0101
PowerFill®

Conditions studied

Small Penis — all drugs for Small Penis →
Penile Enhancement — all drugs for Penile Enhancement →

Sponsor

CHA MEDITECH Co., Ltd.

Who can join

Adults 20 to 65, male only, with Small Penis or Penile Enhancement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aimed to confirm the efficacy and safety of transdermal penis enlargement for 24 weeks after CMDHA0101 injection in subjects who wanted penile enlargement in male patients with small-penis syndrome \*. \*Small-penis syndrome is the anxiety of thinking one's penis is too small - even though it isn't.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Clinical Outcomes between Hyaluronic and Polylactic Acid Filler Injections for Penile Augmentation in Men Reporting a Small Penis: A Multicenter, Patient-Blinded/Evaluator-Blinded, Non-Inferiority, Randomized Comparative Trial with 18 Months of Follow-up.
Yang DY, Jeong HC, Ko K, Lee SH, et al · · 2020 · cited 19× · PMID 32260508 · DOI 10.3390/jcm9041024

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03153735 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CHA MEDITECH Co., Ltd.
Last refreshed: 12 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03153735.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing